After Celgene deal, BMS shoots up pharma market cap rankings

After Celgene deal, BMS shoots up pharma market cap rankings

Source: 
Pharmaforum
snippet: 

Bristol-Myers Squibb $74 billion takeover of Celgene saw it shoot up the list of top 20 pharma companies by market cap into the top 10, according to a new analysis by GlobalData.